Information Delivery. Maker will deliver to Holder:
Information Delivery. To obtain your Fund account statements, confirms and regulatory mailings online instead of in paper form, please provide us with your email address. After your account is opened, we will send you an e-mail with the instructions on how to sign up for electronic information delivery. Email Address:
Information Delivery. Supplier shall keep Maxim apprised of the status of the development work that is part of any Services on an ongoing basis during project review meetings held on a schedule to be agreed upon by the Parties from time to time, and in any event at least once every month.
Information Delivery. The Borrower fails to comply with any obligation to deliver Specified Information, and with respect to a failure that is capable of being remedied, such failure shall continue unremedied for a period of five or more Business Days; or
Information Delivery. Before soliciting the consent or the vote of any holder of Securities for a Reserve Matter Modification, the Issuer shall provide to the Fiscal Agent (for onward distribution to the holders of the Securities that would be affected by that proposed Modification) the following information: (i) a description of the Issuer’s economic and financial circumstances which are, in the Issuer’s opinion, relevant to the request for the proposed Modification, a description of the Issuer’s existing debts and a description of any broad policy reform program and provisional macroeconomic outlook; (ii) if the Issuer shall at the time have entered into an arrangement for financial assistance with multilateral and/or other major creditors or creditor groups and/or an agreement with any such creditors regarding debt relief, (x) a description of any such arrangement or agreement and (y) where permitted under the information disclosure policies of the multilateral or other creditors, as applicable, a copy of the arrangement or agreement; (iii) a description of the Issuer’s proposed treatment of external debt instruments that are not affected by the proposed Modification and its intentions with respect to any other major creditor groups; and (iv) if the Issuer is then seeking a Reserve Matter Modification affecting any other series of Securities, a description of that proposed Modification.
Information Delivery. 1. The information for the establishment of the ISUP NOM 112 call will be sent in block.
Information Delivery. Upon the Completion of Phase II Clinical Trials for the Salix Designated Indication Product, Salix shall deliver to Alfa such information regarding the Salix Designated Indication and Salix Designated Indication Product as Alfa may reasonably request in order to enable Alfa to assess its interest in obtaining a license to the Salix Designated Indication Product; provided, however, that as provided above in this Section 4.2.2, Salix may elect not to present its initial Salix Designated Indication Product to Alfa upon the Completion of Phase II Clinical Trials, and in such case would not have to provide the information required by this Section 4.2.2(a) with regard to the initial Salix Designated Indication Product. Such information shall include, but not be limited to, Phase II Clinical Data of the same type and having substantially the same level of detail of information that Alfa provided to Salix with respect to Crohn’s disease and the Crohn’s EIR Product prior to the Amendment Effective Date. If Salix designates a second Salix Designated Indication Product in replacement for the first Salix Designated Indication Product as described above, then Salix shall deliver to Alfa such information regarding such Salix Designated Indication and Salix Designated Indication Product as Alfa may reasonably request in order to enable Alfa to assess its interest in obtaining the Salix Designated Indication License for such second Salix Designated Indication Product upon the earlier of the Completion of Phase II Clinical Trials for such second Salix Designated Indication Product and the abandonment by Salix of the Development of such second Salix Designated Indication Product. * Confidential treatment requested; certain information omitted and filed separately with the SEC.
Information Delivery. What should trigger required delivery of HSSI? • Fulfillment of a diagnostic order • Completion of a requested referral What HSSI should be delivered? • Diagnostic test results • Referral assessment or diagnosis • Discharge from a hospital or Emergency Department • Referral for clinical consult • Transition to new care setting Relevant Definitions • Completion of a patient-initiated encounter • Discharge summary • Clinical history • Full medial record • Encounter summary Information Delivery: the delivery of HSSI regarding a specific Individual to a specific Participant in conjunction with an Order or Referral. Order or Referral: any request, electronic or otherwise, placed by a health professional for diagnostic services, including but not limited to requests for diagnostic clinical laboratory and radiology services, or for assessment, evaluation, or consultation services from another health or social services professional.
Information Delivery. Before drafting a company-specific agreement, management shall inform union representatives and others on the negotiating committee of the company’s standing, future prospects and personnel policy. The union representative has the right to information regarding wage payments at the workplace he/she represents to the extent necessary to enforce provisions of the company-specific agreement. During the duration of a company-specific agreement, union representatives shall be informed twice a year of the aforementioned items and priorities in the company’s operations. They shall exercise discretion regarding this information to the extent that it is not open to public discussion. Information is only required to be provided to the extent necessary for the provisions of the company-specific agreement. An agreement made on the basis of this chapter shall be made available to the employees of the company concerned. Informing unauthorised parties of the content of the agreement is prohibited.
